126 related articles for article (PubMed ID: 37369303)
1. PET Standardized Uptake Value May Influence Surgical Planning for Clinical Stage IA Non-Small Cell Lung Cancer.
Murillo AD; Kratz JR
Ann Thorac Surg; 2024 May; 117(5):1024. PubMed ID: 37369303
[No Abstract] [Full Text] [Related]
2. Limited resection for clinical Stage IA non-small-cell lung cancers based on a standardized-uptake value index.
Shiono S; Abiko M; Sato T
Eur J Cardiothorac Surg; 2013 Jan; 43(1):e7-e12. PubMed ID: 23129358
[TBL] [Abstract][Full Text] [Related]
3. Impact of FDG PET Standardized Uptake Value in Resected Clinical Stage IA Non-Small Cell Lung Cancer.
Tapias LF; Shen R; Cassivi SD; Reisenauer JS; Lunn BW; Lechtenberg BJ; Nichols FC; Wigle DA; Blackmon SH
Ann Thorac Surg; 2024 May; 117(5):1017-1023. PubMed ID: 37080373
[TBL] [Abstract][Full Text] [Related]
4. PET scan 18F-fluorodeoxyglucose uptake and prognosis in patients with resected clinical stage IA non-small cell lung cancer.
Nair VS; Barnett PG; Ananth L; Gould MK;
Chest; 2010 May; 137(5):1150-6. PubMed ID: 20038738
[TBL] [Abstract][Full Text] [Related]
5. Does positron emission tomography prevent nontherapeutic pulmonary resections for clinical stage IA lung cancer?
Kozower BD; Meyers BF; Reed CE; Jones DR; Decker PA; Putnam JB
Ann Thorac Surg; 2008 Apr; 85(4):1166-9; discussion 1169-70. PubMed ID: 18355490
[TBL] [Abstract][Full Text] [Related]
6. Does FDG PET/CT have a role in determining adjuvant chemotherapy in surgical margin-negative stage IA non-small cell lung cancer patients?
Park HL; Yoo IR; Boo SH; Park SY; Park JK; Sung SW; Moon SW
J Cancer Res Clin Oncol; 2019 Apr; 145(4):1021-1026. PubMed ID: 30756189
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of total lesion glycolysis by 18F-FDG PET/CT in surgically resected stage IA non-small cell lung cancer.
Park SY; Cho A; Yu WS; Lee CY; Lee JG; Kim DJ; Chung KY
J Nucl Med; 2015 Jan; 56(1):45-9. PubMed ID: 25525185
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of positron emission tomography in resected stage IA non-small cell lung cancer.
Chou HP; Lin KH; Huang HK; Lin LF; Chen YY; Wu TH; Lee SC; Chang H; Huang TW
Eur Radiol; 2021 Oct; 31(10):8021-8029. PubMed ID: 33763721
[TBL] [Abstract][Full Text] [Related]
9. Fluorine-18 fluorodeoxyglucose positron emission tomographic maximal standardized uptake value predicts survival independent of clinical but not pathologic TNM staging of resected non-small cell lung cancer.
Downey RJ; Akhurst T; Gonen M; Park B; Rusch V
J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1419-27. PubMed ID: 17532932
[TBL] [Abstract][Full Text] [Related]
10. Occult nodal metastasis in patients with non-small cell lung cancer at clinical stage IA by PET/CT.
Park HK; Jeon K; Koh WJ; Suh GY; Kim H; Kwon OJ; Chung MP; Lee KS; Shim YM; Han J; Um SW
Respirology; 2010 Nov; 15(8):1179-84. PubMed ID: 20573058
[TBL] [Abstract][Full Text] [Related]
11. Tumour standardized uptake value on positron emission tomography is a novel predictor of adenocarcinoma in situ for c-Stage IA lung cancer patients with a part-solid nodule on thin-section computed tomography scan.
Hattori A; Suzuki K; Matsunaga T; Fukui M; Tsushima Y; Takamochi K; Oh S
Interact Cardiovasc Thorac Surg; 2014 Mar; 18(3):329-34. PubMed ID: 24351509
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
[TBL] [Abstract][Full Text] [Related]
13. CyberKnife radiosurgery for inoperable stage IA non-small cell lung cancer: 18F-fluorodeoxyglucose positron emission tomography/computed tomography serial tumor response assessment.
Vahdat S; Oermann EK; Collins SP; Yu X; Abedalthagafi M; Debrito P; Suy S; Yousefi S; Gutierrez CJ; Chang T; Banovac F; Anderson ED; Esposito G; Collins BT
J Hematol Oncol; 2010 Feb; 3():6. PubMed ID: 20132557
[TBL] [Abstract][Full Text] [Related]
14. Maximum standardized uptake value of the primary tumor does not improve candidate selection for sublobar resection.
Muraoka Y; Yoshida Y; Nakagawa K; Ito K; Watanabe H; Narita T; Watanabe SI; ; Yotsukura M; Motoi N; Yatabe Y
J Thorac Cardiovasc Surg; 2022 May; 163(5):1656-1665.e3. PubMed ID: 34275620
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of 18F-FDG PET and CT morphologic features for recurrence in pathological stage IA non-small cell lung cancer.
Ko KH; Hsu HH; Huang TW; Gao HW; Cheng CY; Hsu YC; Chang WC; Chu CM; Chen JH; Lee SC
Medicine (Baltimore); 2015 Jan; 94(3):e434. PubMed ID: 25621697
[TBL] [Abstract][Full Text] [Related]
16. Detection of non-aggressive stage IA lung cancer using chest computed tomography and positron emission tomography/computed tomography.
Shiono S; Yanagawa N; Abiko M; Sato T
Interact Cardiovasc Thorac Surg; 2014 Oct; 19(4):637-43. PubMed ID: 24994703
[TBL] [Abstract][Full Text] [Related]
17. Tumour metabolic activity measured by fluorodeoxyglucose positron emission tomography for radiotherapy planning as a prognostic factor for locally advanced non-small cell lung cancer.
Masarykova A; Scepanovic D; Povinec P; Bires P; Lederleitner D; Pobijakova M
Bratisl Lek Listy; 2018; 119(3):133-138. PubMed ID: 29536740
[TBL] [Abstract][Full Text] [Related]
18. The maximum standardized 18F-fluorodeoxyglucose uptake on positron emission tomography predicts lymph node metastasis and invasiveness in clinical stage IA non-small cell lung cancer.
Maeda R; Isowa N; Onuma H; Miura H; Harada T; Touge H; Tokuyasu H; Kawasaki Y
Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):79-82. PubMed ID: 19366724
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancer.
Li X; Zhang H; Xing L; Xu X; Xie P; Ma H; Zhang L; Chen M; Sun X; Xu W; Chen L; Yu J
Clin Lung Cancer; 2013 Sep; 14(5):568-73. PubMed ID: 23835164
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer.
Higashi K; Ueda Y; Arisaka Y; Sakuma T; Nambu Y; Oguchi M; Seki H; Taki S; Tonami H; Yamamoto I
J Nucl Med; 2002 Jan; 43(1):39-45. PubMed ID: 11801701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
